Autologous Fat Grafting Market By Type (Integrated Fat Transfer Systems, Aspiration and Harvesting Systems, Liposuction Systems, Fat Processing Systems, and De-Epithelialization Devices), By Application (Breast Augmentation, Buttock Augmentation, Facial Fat Grafting, Hand Rejuvenation, and Others), and By Region - Trends, Analysis and Forecast till 2029.

After accounting for USD 358.4 Million in 2019, the autologous fat grafting market is expected to grow at a compound annual growth rate (CAGR) of 13.4% to USD 1255.5 Million by 2029. The analysis.

Autologous fat grafting technology is expected to gain popularity as a potentially non-invasive procedure in aesthetic and reconstructive surgeries. Autologous fat grafting procedures have various benefits such as fast recovery, fewer risks of allergy, and diminished downtime. Over the years, people have realized the benefits of these procedures globally. Further, continuous advancement made in techniques and approaches of harvesting, mainly with respect to the choice of the donor site and wetting solutions, has enhanced the outcomes of the autologous fat transfer technique. This has helped the market to maintain good stead.

Growing aesthetic capability procedures

Pre-pectoral reconstruction of the breast is developing as a productive alternative for sub-muscular implants, as they lead to low risk of post complications, such as muscular impairment, animation deformity, and pain. However, the study on applications of autologous fat grafting technology in pre-pectoral breast reconstruction is still in the nascent stage. Nevertheless, the possibility of superior functional outcomes remains a profitable option for key players in the autologous fat grafting market.

Increasing strategic partnerships and collaborations

MicroAire, Allergan, Human Med, and Alma Lasers are projected to mainly maintain their strategic focus on acquisitions and partnerships with smaller yet active companies. Manufacturers are enhancing their market share in the autologous fat grafting market by investing efforts in introducing innovative products. For instance, in 2019, Alma Lasers (Sisram Medical) proclaimed the availability of BeautiFill as the novel laser-based technique for fat harvesting, whereas leveraging autologous fat to restore the volume to body or face. Further, there has been a surge in demand for adipose-derived stem cells (ADSC), as cellular therapies are increasingly being perceived as a mainstream therapeutic option, which is potentially applicable in regeneration and tissue engineering. In addition, increasing the focus of promient players on developing advanced accessories & systems is likely to extend the applicability of their offerings, leveraging untapped opportunities in the autologous fat grafting market.

However, the risk factor such as injected fat getting reabsorbed by the body may hamper the growth of the target market. Moreover, some of the fat injected into the breast area may result in necrosis, resulting in pain, puss formation, and similar symptoms. Such risks associated with fat grafting procedures will hamper the growth of the market.

The  autologous fat grafting market is segmented based on type, application, and region.

On the basis of type, the autologous fat grafting market is segmented into integrated fat transfer systems, aspiration and harvesting systems, liposuction systems, fat processing systems, and de-epithelialization devices. Based on application, the target market is segmented into breast augmentation, buttock augmentation, facial fat grafting, hand rejuvenation, and others.

Regional Insights:

On region the autologous fat grafting market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is expected to appear as prominent market. This is mainly attributed due to growing numbers of such autologous fat grafting procedure in the U.S. Additionally, incessant technological advancements in these treatments are further expected to boost the growth of market. Asia Pacific is projected to rise to prominence by rising at a high pace.  This is due to growth in the number of awareness programs that promote such processes. Japan is accounted to be one of the most bulging markets in the region.

Segments Covered in the Report:

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2019 to 2029. For the purpose of this study, has segmented the  Autologous Fat Grafting market report based on type, application, and region:

Autologous Fat Grafting Market, By Type:

• Integrated Fat Transfer Systems
• Aspiration and Harvesting Systems
• Liposuction Systems
• Fat Processing Systems
• De-Epithelialization Devices

Autologous Fat Grafting Market, By Application:

• Breast Augmentation
• Buttock Augmentation
• Facial Fat Grafting
• Hand Rejuvenation
• Others

Autologous Fat Grafting Market, By Region:

• North America
  • Middle East & Africa
    • • GCC
      • Israel
      • South Africa
      • Rest of Middle East & Africa
  • Latin America
    • • Brazil
      • Mexico
      • Rest of Latin America
  • Asia Pacific
    • • China
      • India
      • Japan
      • South Korea
      • Rest of Asia Pacific
  • Europe
    • • Germany
      • UK
      • France
      • Russia
      • Italy
      • Rest of Europe
  • • U.S.
    • Canada

The key players operating the autologous fat grafting market includes Allergan plc, Cytori Therapeutics, Inc., Sisram Medical, Ltd (Alma Lasers), Black Tie Medical Inc. (Tulip Medical Inc.), Genesis Biosystems, Inc., HK Surgical Inc., Ranfac Corp., Human Med AG, MicroAire Surgical Instruments, LLC, and Sterimedix Ltd. Prominent players operating in the target market are focusing on the strategic partnerships as well as launching of the products in order to gain competitive edge in the target market. For instance, in November 2018, Alma lasers, one of the top five leading leaders of energy-based medical and aesthetic solutions, announced it has completed the first step of acquiring its Israeli distributor Nova Medical, spreading its business outreach and establishing a direct operation in Israel.

• Allergan plc
• Cytori Therapeutics, Inc.
• Sisram Medical, Ltd (Alma Lasers)
• Genesis Biosystems, Inc.
• Black Tie Medical Inc. (Tulip Medical Inc.)
• Ranfac Corp.
• HK Surgical Inc.
• Human Med AG
• MicroAire Surgical Instruments, LLC
• Sterimedix Ltd.